Conference Activities & Talks -

Division display  81 - 100 of about 166 ／  All the affair displays >>

  1. Hiroki Osumi, Satoshi Matsusaka, Mitsukuni Suenaga, Takeru Wakatsuki, Mariko Ogura, Masato Ozaka, Eiji Shinozaki, Keisho Chin, Nobuyuki Mizunuma. Quantitative analysis of the impact of deepness of response on survival time following patients with metastatic colorectal cancer treated by chemotherapy and anti-EGFR monoclonal antibodies.. ASCO-GI 2014.01 SF, US

  2. Takeru Wakatsuki, Keisho Chin, Satoshi Matsusaka, Mariko Ogura, Masato Ozaka, Mitsukuni Suenaga, Eiji Shinozaki, Izuma Nakayama, Nobuyuki Mizunuma. Exploratory analysis to investigate clinical factors that may influence trastsuzumab efficacy in patients with HER2-positive gastric cancer.. ASCO-GI 2014.01 SF, US

  3. Mitsukuni Suenaga, Nobuyuki Mizunuma, Satoshi Matsusaka, Eiji Shinozaki, Masato Ozaka, Mariko Ogura, Keisho Chin, Toshiharu Yamaguchi.. A phase II study of oxaliplatin reintroduction in patients pretreated with oxaliplatin and irinotecan for advanced colorectal cancer (RE-OPEN study): Reports of interim analysis.. ASCO Gastrointestinal Cancers Symposium 2013.01

  4. Itatani Yoshiro, Akiyoshi Takashi, Kuroyanagi Hiroya, Yamakawa Keiko, Noaki Rota, Konishi Tsuyoshi, Fujimoto Yoshiya, Ueno Masashi, Oya Masatoshi, Suenaga Mitsukuni, Yamaguchi Toshiharu. 病初は切除不能であった、骨盤壁に浸潤する局所進行直腸癌に対するFOLFOX4+bevacizumabと術前化学放射線療法施行後の全直腸間膜切除術　症例報告(Total mesorectal excision of initially unresectable locally advanced rectal cancer infiltrating the pelvic wall after treatment with FOLFOX4 plus bevacizumab and preoperative chemoradiation: report of a case). Surgery Today 2012.01.01

  5. Mitsukuni Suenaga, Satoshi Matsusaka, Nobuyuki Mizunuma, Eiji Shinozaki, Mariko Ogura, Masato Ozaka, Koichi Takagi, Toshiharu Yamaguchi, Kiyohiko Hatake.. Addition of bevacizumab to first-line FOLFOX4 and overall survival in patients with metastatic colorectal cancer.. ASCO Gastrointestinal Cancers Symposium 2012.01

  6. Mitsukuni Suenaga, Satoshi Matsusaka, Eiji Shinozaki, Nobuyuki Mizunuma, Kiyohiko Hatake, Toshiharu Yamaguchi.. A phase I/II study of biweekly XELIRI plus bevacizumab for patients with metastatic colorectal cancer as second-line chemotherapy (BIXER study): Reports of phase I part and interim analysis of phase II part.. ASCO Gastrointestinal Cancers Symposium 2012.01

  7. Yoshihito Ohhara, Mitsukuni Suenaga, Satoshi Matsusaka, Eiji Shinozaki, Nobuyuki Mizunuma, Toshiharu Yamaguchi, Kiyohiko Hatake. Comparison between the three oxaliplatin-based regimens with bevacizumab in patients with metastatic colorectal cancer.. ASCO-GI 2012.01 SF, US

  8. Yoshihito Ohhara, Keisho Chin, Mariko Ogura, Mitsukuni Suenaga, Eiji Shinozaki, Satoshi Matsusaka, Nobuyuki Mizunuma, Toshiharu Yamaguchi, Kiyohiko Hatake. What are the limiting factors related to discontinuance of chemotherapy after failure of first-line S-1 plus CDDP in Japanese patients with advanced gastric cancer?. ASCO-GI 2012.01 SF, US

  9. Kazuyoshi Kawakami, Mitsukuni Suenaga, Takashi Yokokawa, Kazuo Sugita, Yutaro Mae, Eri Nakamoto, Hiroshi Imada, Nobuyuki Mizunuma, Toshiharu Yamaguchi, Toshihiro Hama. Effect of moisturizers on prevention of hand-foot syndrome associated with capecitabine plus oxaliplatin.. ASCO-GI 2012.01 SF, US

  10. Eiji Shinozaki, Noriko Yamamoto, Keisho Chin, Mariko Ogura, Mitsukuni Suenaga, Satoshi Matsusaka, Nobuyuki Mizunuma, Toshiharu Yamaguchi, Kiyohiko Hatake. How many biopsy fragments will be necessary to assess HER2 status for gastric cancer?. ASCO-GI 2012.01 SF, US

  11. Toshiyasu Watanabe, Eiji Shinozaki, Sho Kijima, Yoshihito Ohhara, Yasutoshi Kuboki, Koichi Takagi, Masato Ozaka, Mariko Ogura, Yoshinori Kikuchi, Mitsukuni Suenaga, Keisho Chin, Satoshi Matsusaka, Junichi Koike, Kimihiko Funahashi, Yoshihisa Urita, Nobuyuki Mizunuma, Kiyohiko Hatake, Hironori Kaneko, Motonobu Sugimoto. Does panitumumab have a clinical benefit in cetuximab-refractory KRAS wild-type metastatic colorectal cancer?. ASCO-GI 2012.01

  12. Satoshi Matsusaka, Mitsukuni Suenaga, Yuji Mishima, Yasuhito Terui, Eiji Shinozaki, Nobuyuki Mizunuma, Kiyohiko Hatake. Circulating tumor cells as a surrogate marker for determining response to chemotherapy in Japanese patients with metastatic colorectal cancer.. ASCO-GI 2012.01

  13. Dai Inoue, Satoshi Matsusaka, Noriko Yamamoto, Mitsukuni Suenaga, Yuji Mishima, Eiji Shinozaki, Yasuhito Terui, Nobuyuki Mizunuma, Yuichi Ishikawa, Kiyohiko Hatake. CD133 status influences in prognosis of patients with metastatic colorectal cancer receiving cetuximab.. ASCO-GI 2012.01 SF, US

  14. Yoshitaka HONMA, Masataka TAGURI , Narikazu BOKU, Takahiro TSUSHIMA, Hideaki TAKAHASHI, Shinya UEDA, Tomohiro NISHINA, Hiroki KAWAI, Shunsuke KATO, Mitsukuni SUENAGA. Prognostic Factors of 127 Patients with Advanced Small-bowel Adenocarcinoma Treated with Systemic Chemotherapy. . ECCO annual meeting 2011.09

  15. akahashi Hideaki, Taguri Masataka, Boku Narikazu, Tsushima Takahiro, Honma Yoshitaka, Ueda Shinya, Nishina Tomohiro, Kawai Hiroki, Kato Shunsuke, Kunieda Kenji, Suenaga Mitsukuni, Tamura Fumio, Uchino Keita, Hata Yasuhiro, Horimatsu Takahiro. Prognostic factors of 127 patients with advanced small-bowel adenocarcinoma treated with systemic chemotherapy. 第9回日本臨床腫瘍学会学術集会 2011.07.22 横浜

  16. 大場 大, 陳 勁松, 篠崎 英司, 末永 光邦, 松阪 諭, 水沼 信之, 畠 清彦, 山口 俊晴. Second-line settingでのCPT-11の利用は進行性胃癌の生存率を向上させる(Availability of CPT-11 in second-line setting provides survival benefit for advanced gastric cancer). 日本消化器外科学会総会 2011.07.01

  17. Matsusaka Satoshi, Suenaga Mitsukuni, Mishima Yuji, Kuniyoshi Ryoko, Takagi Koichi, Terui Yasuhito, Mizunuma Nobuyuki, Hatake Kiyohiko. 転移性結腸直腸癌の日本人患者における化学療法に対する反応性を決定するためのサロゲートマーカーとしての循環中腫瘍細胞(Circulating tumor cells as a surrogate marker for determining response to chemotherapy in Japanese patients with metastatic colorectal cancer). Cancer Science 2011.06.01

  18. S. Matsusaka, N. Mizunuma, M. Suenaga, K. Chin, E. Shinozaki, T. Watanabe, Y. Kawazoe, Y. Kuboki, Y. Terui, K. Hatake. Use of circulating endothelial cells to predict response to FOLFOX4 plus bevacizumab in metastatic colorectal cancer.. ASCO Gastrointestinal Cancers Symposium 2011.01.22 SF, US

  19. T. Tsushima, N. Boku, Y. Honma, H. Takahashi, S. Ueda, T. Nishina, H. Kawai, S. Kato, M. Suenaga, F. Tamura. Retrospective analysis of first-line chemotherapy in 132 patients with advanced small-bowel adenocarcinoma.. ASCO Gastrointestinal Cancers Symposium 2011.01.21 SF, US

  20. S. Matsusaka, K. Chin, N. Mizunuma, M. Ogura, M. Suenaga, M. Ozaka, K. Takagi, M. Oba, Y. Mishima, K. Hatake. Use of circulating tumor cells to predict response to chemotherapy in patients with advanced gastric cancer.. ASCO Gastrointestinal Cancers Symposium 2011.01.20 SF, US

< PREV - NEXT >

To the head of this page.▲